Grown Rogue International (GRUSF) Non-Current Deferred Tax Liability (2024)
Grown Rogue International's (GRUSF) quarterly Non-Current Deferred Tax Liability came in at $58181.0 in Q4 2024.
Grown Rogue International (GRUSF) Non-Current Deferred Tax Liability (2024) Analysis & Trends
Grown Rogue International's Non-Current Deferred Tax Liability history runs 1 years deep, the most recent figure standing at $58181.0 for Q4 2024.
- On a quarterly basis, Non-Current Deferred Tax Liability changed N/A year-over-year to $58181.0 in Q4 2024; TTM through Dec 2024 was $58181.0, a N/A change from a year earlier, with the FY2024 full-year figure at $58181.0, changed N/A from the prior year.
- Non-Current Deferred Tax Liability held at $58181.0 in Q4 2024 per GRUSF's latest filing.
- Across five years, Non-Current Deferred Tax Liability topped out at $58181.0 in Q4 2024 and bottomed at $58181.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 58,181.00 |
| Dec 31, 2024 | 58,181.00 |